Ignite Creation Date:
2024-05-06 @ 3:35 AM
Last Modification Date:
2024-10-26 @ 11:35 AM
Study NCT ID:
NCT02322216
Status:
COMPLETED
Last Update Posted:
2017-11-17
First Post:
2014-12-17
Brief Title:
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
Sponsor:
Alcon Research
Organization:
Alcon Research
Study Overview
Official Title:
A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 02 QD vs Olopatadine Hydrochloride Ophthalmic Solution 01 BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate olopatadine 02 QD once per day compared to olopatadine 01 BID twice per day in the treatment of ocular itching associated with allergic conjunctivitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2016-004317-27 | EUDRACT_NUMBER | None | None |